Conventional antidepressants are widely employed in several psychiatric and neurologic disorders, yet the mechanisms underlying their delayed and partial therapeutic effects are only gradually being understood. This narrative review provides an up-to-date overview of the interplay between antidepressant treatment and Brain-Derived Neurotrophic Factor (BDNF) signaling. In addition, the impact of nutritional, environmental and physiological factors on BDNF and the antidepressant response is outlined. This review underlines the necessity to include information on lifestyle choices in testing and developing antidepressant treatments in the future
Major depressive disorder (MDD) is a neuropsychiatric condition that is becoming increasingly preval...
Increased glutamatergic neurotransmission and synaptic plasticity in the prefrontal cortex have been...
The traditional "brain-derived neurotrophic factor (BDNF) hypothesis of depression" proposes that im...
Conventional antidepressants are widely employed in several psychiatric and neurologic disorders, ye...
Levels of brain-derived neurotrophic factor (BDNF) are reduced in the brain and serum of depressed p...
Brain-derived neurotrophic factor (BDNF) signaling through its receptor TrkB has for a long time bee...
Neurotrophic factors, particularly BDNF (brain-derived neurotrophic factor), have been associated wi...
The role of brain-derived neurotrophic factor (BDNF) and its receptor TrkB has been studied in the c...
Despite growing evidence that increased brain-derived neurotrophic factor (BDNF) and hippocampal adu...
Depression is a neuropsychiatric disorder affecting a huge percentage of the active population espec...
Depression and posttraumatic stress disorder are assumed to be maladaptive responses to stress and a...
The traditional "brain-derived neurotrophic factor (BDNF) hypothesis of depression" propos...
BACKGROUND:Brain derived neurotrophic factor (BDNF) is one of the most important regulatory proteins...
Selective delta opioid receptor agonists have been shown to produce antidepressant-like behavioral e...
Modern neurological approaches enable detailed studies on the pathophysiology and treatment of depre...
Major depressive disorder (MDD) is a neuropsychiatric condition that is becoming increasingly preval...
Increased glutamatergic neurotransmission and synaptic plasticity in the prefrontal cortex have been...
The traditional "brain-derived neurotrophic factor (BDNF) hypothesis of depression" proposes that im...
Conventional antidepressants are widely employed in several psychiatric and neurologic disorders, ye...
Levels of brain-derived neurotrophic factor (BDNF) are reduced in the brain and serum of depressed p...
Brain-derived neurotrophic factor (BDNF) signaling through its receptor TrkB has for a long time bee...
Neurotrophic factors, particularly BDNF (brain-derived neurotrophic factor), have been associated wi...
The role of brain-derived neurotrophic factor (BDNF) and its receptor TrkB has been studied in the c...
Despite growing evidence that increased brain-derived neurotrophic factor (BDNF) and hippocampal adu...
Depression is a neuropsychiatric disorder affecting a huge percentage of the active population espec...
Depression and posttraumatic stress disorder are assumed to be maladaptive responses to stress and a...
The traditional "brain-derived neurotrophic factor (BDNF) hypothesis of depression" propos...
BACKGROUND:Brain derived neurotrophic factor (BDNF) is one of the most important regulatory proteins...
Selective delta opioid receptor agonists have been shown to produce antidepressant-like behavioral e...
Modern neurological approaches enable detailed studies on the pathophysiology and treatment of depre...
Major depressive disorder (MDD) is a neuropsychiatric condition that is becoming increasingly preval...
Increased glutamatergic neurotransmission and synaptic plasticity in the prefrontal cortex have been...
The traditional "brain-derived neurotrophic factor (BDNF) hypothesis of depression" proposes that im...